Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 989, doi. 10.32604/or.2023.030395
- By:
- Publication type:
- Article
Works matching IS 09650407 AND DT 2023 AND VI 31 AND IP 6
Results: 13
1
2
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 967, doi. 10.32604/or.2023.042309
- By:
- Publication type:
- Article
3
ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 955, doi. 10.32604/or.2023.029638
- By:
- Publication type:
- Article
4
Polo-like kinase 1 suppresses lung adenocarcinoma immunity through necroptosis.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 937, doi. 10.32604/or.2023.030933
- By:
- Publication type:
- Article
5
CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 929, doi. 10.32604/or.2023.030611
- By:
- Publication type:
- Article
6
CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 917, doi. 10.32604/or.2023.030425
- By:
- Publication type:
- Article
7
Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined in silico and in vitro approach.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 899, doi. 10.32604/or.2023.030760
- By:
- Publication type:
- Article
8
The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 887, doi. 10.32604/or.2023.030184
- By:
- Publication type:
- Article
9
Progress in research on tumor microenvironment-based spatial omics technologies.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 877, doi. 10.32604/or.2023.029494
- By:
- Publication type:
- Article
10
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 867, doi. 10.32604/or.2023.030411
- By:
- Publication type:
- Article
11
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 855, doi. 10.32604/or.2023.030374
- By:
- Publication type:
- Article
12
Deoxynortryptoquivaline: A unique antiprostate cancer agent.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 845, doi. 10.32604/or.2023.030266
- By:
- Publication type:
- Article
13
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling.
- Published in:
- Oncology Research, 2023, v. 31, n. 6, p. 833, doi. 10.32604/or.2023.030241
- By:
- Publication type:
- Article